Understanding how to choose a pharmaceutical distributor is essential for manufacturers planning to introduce or expand healthcare products in Iraq. The distributor you appoint influences product availability, customer service, inventory management, commercial visibility, and the way your brand reaches pharmacies and healthcare facilities.
A company with an impressive presentation may still lack suitable storage, reliable account coverage, or the reporting systems needed to manage your portfolio. Another distributor may have strong logistics but limited experience supporting the product category you intend to launch.
The right decision therefore requires evidence. Manufacturers should evaluate legal authorization, quality systems, market access, financial capacity, and operational performance before committing to a long-term relationship.
This guide explains the pharmaceutical distributor selection process, the documents to request, the questions to ask, and the warning signs to investigate when choosing a distribution partner for Iraq.
What Does a Pharmaceutical Distributor Do?
A pharmaceutical distributor connects manufacturers with authorized customers through activities such as purchasing, storage, inventory management, order fulfillment, and delivery. Depending on the agreed scope and applicable permissions, a local partner may also coordinate regulatory support, account development, or commercial reporting.
These responsibilities should never be assumed. Distribution, product registration, scientific representation, and promotional execution are different functions, even when one organization offers several of them.
Before evaluating candidates, decide which services your company needs and which responsibilities will remain with the manufacturer or another qualified partner.
For an explanation of the operational journey, read how pharmaceutical distribution works.
A clear understanding of these functions prevents manufacturers from selecting a partner based on a service description that does not match the actual requirements of their product.
Why Distributor Selection Matters in Iraq
Choosing a pharmaceutical distributor in Iraq requires more than comparing warehouse locations or proposed margins. The partner must fit your intended product category, sales channels, geographic scope, and commercial development plan.
For example, a distributor serving community pharmacies may not have the same capabilities as a partner supporting specialist clinics or institutional procurement. Coverage in one region does not automatically demonstrate dependable service across every intended territory.
Begin with the wider environment. The Iraq healthcare market overview provides useful context for understanding healthcare channels and market-entry considerations.
When considering how to choose a pharmaceutical distributor, ask whether the candidate can support the specific customers your product needs to reach. General market presence is useful, but relevant account access and operational consistency matter more than broad claims.
The aim is to establish a partnership that can maintain product quality and availability while giving the manufacturer enough information to manage growth responsibly.
1. Define Your Distribution Requirements First
The first step in pharmaceutical distributor selection is preparing a clear requirements brief. Without it, candidates may submit proposals based on different assumptions, making comparisons unreliable.
Describe your product portfolio, intended customer segments, storage conditions, initial geographic priorities, and expected launch sequence. Identify whether the products require specialized handling or particular technical knowledge.
Your brief should also clarify the support you expect beyond logistics. This may include account onboarding, demand planning, pharmacy engagement, field execution, or reporting.
Specify the difference between essential capabilities and desirable additions. For example, suitable storage for a temperature-sensitive product is essential, while an advanced commercial dashboard may be useful but negotiable.
Companies still developing their entry model can consult how to enter the Iraqi pharmaceutical market before approaching potential partners.
The result should be a consistent document that every shortlisted distributor uses to prepare its proposal.
2. Verify Legal Identity and Applicable Authorizations
Learning how to choose a pharmaceutical distributor begins with verifying who will actually perform the contracted activities.
Request the organization’s legal name, ownership information, relevant registrations, applicable licenses, and details of the facilities and entities involved. Check that the documents correspond to the company named in the proposed agreement.
Do not rely on a logo, website statement, or certificate image without understanding its scope. A document may apply to a particular facility, activity, product category, or period.
Where relevant, confirm validity and authorization through the appropriate issuing authority or qualified local specialists. Requirements should be assessed for the planned products, activities, and territories.
If separate entities will handle importation, warehousing, scientific representation, or downstream distribution, identify each one and document its role.
A reliable candidate should explain its operating structure clearly and provide reasonable evidence. Unexplained discrepancies between company names, contracting entities, and licenses should be resolved before appointment.
3. Assess Regulatory Coordination Without Confusing It With Distribution
A distributor may help coordinate regulatory work, but commercial distribution capability does not prove registration expertise.
Ask who will manage the product documentation, respond to regulatory questions, track submissions, and maintain the relevant records. Confirm whether this work will be performed internally or through another qualified organization.
The manufacturer should retain visibility into submission status, outstanding requirements, and the responsibilities associated with each product.
For medicines, the drug registration process in Iraq can help structure the initial discussion.
Mixed portfolios require separate assessments. A candidate handling nutritional products should understand the relevant supplement registration requirements in Iraq.
Likewise, companies supplying devices should evaluate experience relevant to Iraq medical device registration.
The key question is whether the proposed team has the appropriate capability for your products, supported by named responsibilities and a documented workflow.
4. Inspect Storage and Quality Management Capabilities
A warehouse visit is one of the most useful steps in pharmaceutical distributor due diligence. It allows the manufacturer to compare the candidate’s procedures with its actual operations.
Review receiving arrangements, storage areas, stock identification, access controls, cleaning procedures, and the separation of products awaiting a decision from saleable inventory.
Ask how the team handles damaged goods, returns, expiry dates, and products subject to a quality concern. Review relevant records and investigate how discrepancies are resolved.
WHO’s Good Storage and Distribution Practices for Medical Products provides an international reference for assessing risks during storage, handling, transportation, and distribution. It should be considered alongside applicable local requirements and product specifications. who.int
When assessing how to choose a pharmaceutical distributor, look for consistency between written procedures, staff explanations, and available records. A well-written policy is useful only if the operating team understands and follows it.
5. Evaluate Temperature-Controlled Storage and Transport
Products with temperature requirements need an assessment covering the complete delivery journey. Suitable warehouse conditions alone do not establish that transportation and customer handover are adequately controlled.
Ask the candidate to explain the approved storage range, monitoring arrangements, equipment maintenance, alarm handling, and response to a temperature excursion.
For relevant products, request evidence supporting the suitability of packaging and transport arrangements. Establish who reviews monitoring records and decides whether affected stock can be released.
Business continuity deserves attention. Ask what happens if refrigeration, electricity, a vehicle, or a monitoring device fails.
WHO’s distribution guidance collection includes resources on temperature-sensitive products, storage facilities, transport operations, and monitoring systems. who.int
Lamassu Health’s supply chain and quality management services are relevant to companies coordinating these operational requirements.
6. Verify Market Coverage With Account-Level Evidence
A pharmaceutical distribution network should be evaluated through service capability, not the number of locations marked on a presentation.
Ask which regions the candidate currently serves, which customer categories it reaches, and how frequently deliveries take place. Distinguish direct coverage from coverage provided by downstream partners.
Request recent, appropriately anonymized evidence showing account activity, order frequency, and delivery performance. Commercial confidentiality can be respected without replacing evidence with unsupported claims.
Discuss priority areas such as Baghdad, Basra, Mosul, or other intended markets individually. Each proposed territory should have a realistic service plan.
The guide to pharmaceutical distribution channels in Iraq can help identify the routes relevant to your portfolio.
Knowing how to choose a pharmaceutical distributor means asking whether target accounts can obtain products repeatedly and reliably. A historic customer list does not demonstrate current access or consistent replenishment.
7. Examine the Pharmacy Distribution Network
Pharmacy coverage is particularly important for brands relying on community-pharmacy availability. Evaluate whether the distributor reaches outlets relevant to your category and can maintain an effective reorder process.
Ask how pharmacies are segmented, how new accounts are onboarded, and what ordering methods are available. Understand delivery minimums, service frequency, payment arrangements, and follow-up responsibilities.
A candidate may have many pharmacy contacts while generating limited activity within your intended category. Ask for evidence of comparable products and the account support used to sustain their availability.
For additional context, review pharmacy distribution network Iraq.
The assessment should also investigate stock availability after the first delivery. Initial product placement can create a misleading impression of coverage if pharmacies cannot reorder efficiently.
A smaller network with dependable service may be more suitable for an initial launch than broader coverage with unclear operational control.
8. Assess Product Category Experience and Portfolio Conflicts
Relevant experience can reduce the time needed to understand customer requirements, handling conditions, and commercial priorities.
Ask which comparable products the candidate has supported and what its role involved. Experience distributing OTC products, for example, should not automatically be treated as evidence of capability with specialist prescription medicines.
Review the existing portfolio for competing brands and potential resource conflicts. A distributor may be able to handle overlapping categories responsibly, but the arrangement needs transparency.
Discuss how account attention, field resources, inventory funding, and marketing activity will be allocated. Identify whether your brand will receive a dedicated plan or join a large portfolio without defined support.
When considering how to choose a pharmaceutical distributor, focus on category fit and commitment. The most experienced company may still be unsuitable if it cannot explain how your products will receive adequate operational and commercial attention.
9. Review Pharmacy and Clinic Engagement Capabilities
Distribution makes products available; professional account engagement helps customers understand the approved product information and the practical supply arrangements.
Ask whether the candidate provides engagement support, who performs it, and how activities are reviewed. Confirm the distinction between logistical account service, promotional communication, and medical information.
For pharmacy-focused products, review the proposed pharmacy engagement strategies. Useful support may include approved information, ordering guidance, availability updates, and clear complaint channels.
For products relevant to clinics, discuss a suitable clinic engagement strategy based on the intended professional audience.
Assess the quality of these interactions rather than relying exclusively on visit totals. Ask how the team records questions, resolves availability problems, and escalates medical inquiries.
All communication should remain within the applicable requirements and the approved scope for the product.
10. Evaluate Field Team Capacity and Training
If field execution is included in the partnership, assess the people who will carry out the plan.
Request information on team structure, territory allocation, supervision, training, and workload. Establish whether staff already manage portfolios that may limit their capacity to support your launch.
Representatives should understand approved product messages, relevant safety information, ordering processes, and escalation responsibilities. Training should include practical assessment rather than attendance records alone.
The pharmaceutical field force effectiveness article offers a relevant framework for connecting territory planning, coaching, and performance.
Ask the candidate to demonstrate how a representative would handle a medical question outside their scope or report a suspected adverse event.
An answer to how to choose a pharmaceutical distributor should therefore include field quality whenever commercial execution forms part of the contract. Staffing numbers alone cannot establish readiness.
11. Examine Financial Capacity and Commercial Terms
A distribution partner needs sufficient financial capacity to support the agreed operating model. Delayed payments or inadequate working capital can disrupt product availability and damage the relationship.
Request suitable financial information, trade references, and an explanation of how inventory purchases and customer credit are managed. The depth of review should reflect the size and risk of the proposed commitment.
Clarify payment dates, currency arrangements, credit limits, and responsibility for collection. Discuss how disputes, overdue accounts, and changes in commercial conditions will be handled.
Compare the full cost of the arrangement. A low distribution margin may be offset by additional fees, weak service, excessive inventory demands, or unclear returns obligations.
Use the Iraq pharmaceutical market size article for market context, while keeping your financial model grounded in product-specific demand and realistic account uptake.
The proposed terms should support continuity without encouraging unnecessary stock accumulation.
12. Test Reporting and Inventory Visibility
Transparent reporting helps manufacturers understand whether products are reaching customers and whether supply plans need adjustment.
Request a sample report before signing. It should show the information the distributor can provide consistently, rather than an ideal format it has never produced.
Useful fields may include product code, batch, expiry date, stock quantity, orders, sales, returns, and account activity where available and appropriate.
Distinguish manufacturer sales to the distributor from distributor sales into the market. These measure different stages of product movement and should not be combined without explanation.
When deciding how to choose a pharmaceutical distributor, ask the candidate to trace a sample batch from receipt through current stock and dispatch records.
Also confirm reporting frequency, data ownership, confidentiality, and correction procedures. Manufacturers need usable information, with definitions that remain consistent across review periods.
13. Verify Traceability, Complaints, and Recall Readiness
A distributor must be able to locate affected stock and support the agreed response when a product issue arises.
Ask how batches are recorded at receipt and dispatch, which records are retained, and how affected accounts can be identified. Review the controls for stock placed on hold.
A practical recall exercise can test these capabilities. Select a sample batch and ask the team to identify remaining inventory, relevant dispatches, and the communication pathway.
Review product complaint and suspected adverse-event procedures separately. Staff should know which information to record, who receives it, and what timelines apply under the relevant obligations.
These responsibilities should be documented between the manufacturer, distributor, and any other appointed parties.
Pharmaceutical distributor due diligence should establish that safety and quality matters receive prompt attention, even when they arise outside normal business hours or through downstream customers.
14. Understand Sub-Distributor and Outsourced Operations
Some candidates rely on other organizations for warehousing, transport, or regional distribution. Outsourcing can be appropriate, but responsibilities and oversight must remain clear.
Ask the candidate to identify the organizations involved and explain how they are approved, monitored, and managed.
Review whether relevant quality expectations, reporting duties, and product-handling instructions extend to those parties. Establish whether your agreement requires notification or approval before important partners change.
A distributor should not claim full control over national coverage if it cannot explain how downstream performance is assessed.
The manufacturer should understand where operational visibility ends and which records can be obtained when needed.
This stage is especially useful when comparing a directly managed network with a model built around regional partners. Both should be evaluated against the same product requirements and service expectations.
15. Assess Launch Support Before Awarding the Portfolio
A distributor’s routine operations may be suitable for established products but insufficient for a new brand introduction.
Ask for a product-specific launch proposal covering initial accounts, stock planning, team preparation, approved materials, ordering readiness, and early reporting.
Evaluate whether the candidate’s proposed targets follow from market evidence and available capacity. Large opening orders should not substitute for a plan to generate sustainable downstream demand.
Connect the distributor assessment with your pharmaceutical brand launch checklist so that partner responsibilities become part of the wider readiness review.
Knowing how to choose a pharmaceutical distributor includes understanding what happens after the first shipment. The partner should explain how it will monitor uptake, identify service gaps, and revise the plan when assumptions prove inaccurate.
A credible proposal identifies both the intended results and the work required to achieve them.
How to Choose a Pharmaceutical Distributor Using a Scorecard
A scorecard helps compare candidates consistently. Define the evaluation criteria before reviewing commercial offers, then require evidence for each score.
One practical approach is to rate capabilities from zero to five:
- Zero: no usable evidence.
- One: significant unresolved gaps.
- Two: partial capability requiring substantial improvement.
- Three: suitable capability supported by basic evidence.
- Four: strong capability with demonstrated performance.
- Five: strong capability that closely matches the portfolio’s specific needs.
Assess legal authorization, quality systems, relevant account coverage, financial capacity, reporting, category experience, and launch support.
Set mandatory approval conditions separately. A high commercial score must not compensate for a missing required authorization or an unresolved critical quality issue.
Weight the remaining criteria according to your products. Temperature-control capability, for example, deserves greater emphasis when it is essential to the portfolio.
Record the reasons for the final decision so that the appointment can be reviewed against the original expectations.
Questions to Ask Before Signing a Distribution Agreement
The final meeting should resolve the practical details that determine how the relationship will operate.
Ask the shortlisted candidate:
- Which legal entity will sign and perform the agreement?
- Which facilities and downstream partners will handle the products?
- Which target accounts can be served from the start?
- How will stock and batch information be reported?
- What happens when demand exceeds available inventory?
- How are returns, complaints, and expiry risks managed?
- Who handles urgent safety and quality escalation?
- Which staff and resources are committed to the portfolio?
- What evidence supports the proposed sales forecast?
- How will performance gaps be corrected?
Document the answers and carry relevant commitments into the agreement and operating procedures.
Verbal assurances can help explain a proposal, but they should not replace clear responsibilities for essential activities.
Review Exclusivity and Contract Responsibilities Carefully
Exclusivity should reflect the proposed scope, investment, and demonstrated capabilities. Avoid assuming that one exclusive arrangement must cover every product, channel, and territory.
Define the included products, geographic boundaries, duration, and performance review process. Discuss how rights may change if agreed conditions are not met.
The pharmaceutical distribution agreement should also address ordering, payment, approved commercial terms, quality responsibilities, reporting, confidentiality, and business continuity.
Where regulatory coordination is involved, clarify access to documentation and the arrangements required if the relationship ends. Transition planning should consider ongoing product obligations and continuity of supply.
Contract provisions need review by qualified advisers familiar with the relevant jurisdiction and operating model.
Understanding how to choose a pharmaceutical distributor includes planning for disagreement and transition while both parties can negotiate constructively.
Warning Signs During Distributor Due Diligence
Several issues deserve investigation before appointment.
A candidate may avoid providing current authorization documents, refuse reasonable facility access, or offer inconsistent explanations about its legal structure.
Other concerns include unclear sub-distributor relationships, unsupported national coverage claims, incomplete stock records, and resistance to routine performance reporting.
Commercial warning signs include forecasts without assumptions, excessive opening-order demands, unexplained fees, and pressure to grant broad exclusivity before due diligence is complete.
Quality concerns may include missing records, poor segregation of returned goods, or staff who cannot explain how complaints and temperature excursions are escalated.
A warning sign does not always prove that a candidate is unsuitable. It does mean the issue should be investigated, documented, and resolved before the manufacturer commits.
Confirm the Decision Through a Structured Onboarding Plan
Once a candidate passes the necessary checks, onboarding should test whether the agreed operating model works.
Confirm product records, account setup, ordering procedures, reporting templates, quality contacts, and team training before authorized commercial supply begins.
Where feasible, use a defined initial scope to evaluate fulfillment, communication, and inventory visibility. A pilot does not replace required approvals or quality checks.
Review early results against the agreed service expectations. Identify the cause of any failure and assign corrective actions before expanding activity.
Companies seeking coordinated local support can explore nationwide healthcare distribution services alongside their product-specific requirements.
The appointment should lead to a managed partnership, with regular reviews and evidence-based decisions about growth.
Frequently Asked Questions
How to choose a pharmaceutical distributor for a new market?
Start by defining product and channel requirements. Verify applicable authorizations, inspect quality and storage capabilities, assess relevant account coverage, review financial capacity, and test reporting. Compare candidates using consistent criteria before negotiating the final agreement.
What documents should manufacturers request?
Request legal identity information, applicable licenses, relevant quality procedures, facility details, sample reports, suitable financial information, and references. Additional evidence should reflect the product category, handling conditions, territory, and services included in the partnership.
Is the largest distributor always the best choice?
Size alone does not establish suitability. A smaller distributor may provide stronger category focus, more relevant account access, or clearer reporting. The decision should follow verified capabilities and the resources committed to your portfolio.
What is the difference between a distributor and a regulatory representative?
A distributor manages agreed commercial supply activities. A regulatory representative performs the relevant regulatory role. One organization may provide both functions where appropriately authorized, but the responsibilities must be defined and assessed separately.
How can manufacturers verify pharmacy coverage?
Request recent evidence of active accounts, ordering frequency, delivery performance, and relevant category activity. Distinguish directly served pharmacies from those reached through downstream partners, and assess whether replenishment is dependable.
Should manufacturers grant exclusivity immediately?
Exclusivity should follow due diligence and a clear agreement on scope, resources, and performance expectations. Product, channel, or territory limitations may be appropriate. The final structure requires qualified contractual review.
Which distributor KPIs should be monitored?
Useful measures include order fulfillment, delivery performance, product availability, inventory accuracy, repeat ordering, expiry exposure, payment performance, and reporting timeliness. Definitions and targets should match the portfolio and agreed services.
Can one distributor handle medicines, supplements, and devices?
Possibly, but capability should be evaluated separately for each category. Confirm the applicable authorizations, regulatory expertise, handling arrangements, technical knowledge, and account access instead of relying on general healthcare experience.
Build a Distribution Partnership Around Verified Capabilities
Knowing how to choose a pharmaceutical distributor means connecting your product requirements with evidence of legal, operational, quality, and commercial capability.
For Iraq, assess the accounts and territories the partner can serve reliably, the controls protecting product quality, and the information you will receive after launch. Make responsibilities clear before the first shipment and review performance throughout the relationship.
Lamassu Health’s healthcare services in Iraq cover market-entry support, regulatory coordination, distribution, commercial execution, and reporting. Manufacturers can use these service areas to structure a discussion around their portfolio and required local support. Lamassu Health
Share your product categories, intended channels, storage requirements, and launch priorities with the prospective partner. A well-defined brief creates the foundation for a distribution relationship that can support dependable market access and sustainable brand development.